159 related articles for article (PubMed ID: 1998731)
1. Lung calcium-dependent phospholipid-binding proteins: structure and function.
Tsao FH; Hull WM; Strickland MS; Whitsett JA; Foo TK; Zografi G; DeLuca PM
Biochim Biophys Acta; 1991 Jan; 1081(2):141-50. PubMed ID: 1998731
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of two rabbit lung Ca2(+)-dependent phospholipid-binding proteins.
Tsao FH
Biochim Biophys Acta; 1990 Jun; 1045(1):29-39. PubMed ID: 2369584
[TBL] [Abstract][Full Text] [Related]
3. Characterization of lipocortin I and an immunologically unrelated 33-kDa protein as epidermal growth factor receptor/kinase substrates and phospholipase A2 inhibitors.
Haigler HT; Schlaepfer DD; Burgess WH
J Biol Chem; 1987 May; 262(14):6921-30. PubMed ID: 3032981
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids.
Davidson FF; Dennis EA; Powell M; Glenney JR
J Biol Chem; 1987 Feb; 262(4):1698-705. PubMed ID: 2948959
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of phospholipase A2 inhibitory proteins in human mononuclear cells.
Coméra C; Rothhut B; Russo-Marie F
Eur J Biochem; 1990 Feb; 188(1):139-46. PubMed ID: 2138536
[TBL] [Abstract][Full Text] [Related]
6. Placental anticoagulant proteins: isolation and comparative characterization four members of the lipocortin family.
Tait JF; Sakata M; McMullen BA; Miao CH; Funakoshi T; Hendrickson LE; Fujikawa K
Biochemistry; 1988 Aug; 27(17):6268-76. PubMed ID: 2975506
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies specific to a Ca2(+)-bound form of lipocortin I distinguish its Ca2(+)-dependent phospholipid-binding ability from its ability to inhibit phospholipase A2.
Hayashi H; Owada MK; Sonobe S; Domae K; Yamanouchi T; Kakunaga T; Kitajima Y; Yaoita H
Biochem J; 1990 Aug; 269(3):709-15. PubMed ID: 2143895
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of calcium sensitivity of lipocortin I in phospholipid binding induced by limited proteolysis and phosphorylation at the amino terminus as analyzed by phospholipid affinity column chromatography.
Ando Y; Imamura S; Hong YM; Owada MK; Kakunaga T; Kannagi R
J Biol Chem; 1989 Apr; 264(12):6948-55. PubMed ID: 2540167
[TBL] [Abstract][Full Text] [Related]
9. Isolation of two 67 kDa calcium-binding proteins from pig lung differing in affinity for phospholipids and in anti-phospholipase A2 activity.
Fauvel J; Vicendo P; Roques V; Ragab-Thomas J; Granier C; Vilgrain I; Chambaz E; Rochat H; Chap H; Douste-Blazy L
FEBS Lett; 1987 Sep; 221(2):397-402. PubMed ID: 2957233
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of secreted phospholipases A2 by annexin V. Competition for anionic phospholipid interfaces allows an assessment of the relative interfacial affinities of secreted phospholipases A2.
Buckland AG; Wilton DC
Biochim Biophys Acta; 1998 Apr; 1391(3):367-76. PubMed ID: 9555096
[TBL] [Abstract][Full Text] [Related]
11. Regulatory aspects of mitochondrial phospholipase A2 from rat liver: effects of proteins, phospholipids and calcium ions.
Lenting HB; Neys FW; van den Bosch H
Biochim Biophys Acta; 1988 Jul; 961(1):129-38. PubMed ID: 2968122
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human cytosolic phospholipase A2 by human annexin V.
Buckland AG; Wilton DC
Biochem J; 1998 Jan; 329 ( Pt 2)(Pt 2):369-72. PubMed ID: 9425121
[TBL] [Abstract][Full Text] [Related]
13. A phospholipase A2 in the supernatant fraction of rat spleen. Its similarity to rat pancreatic phospholipase A2.
Tojo H; Ono T; Kuramitsu S; Kagamiyama H; Okamoto M
J Biol Chem; 1988 Apr; 263(12):5724-31. PubMed ID: 3128547
[TBL] [Abstract][Full Text] [Related]
14. Lipocortin-like anti-phospholipase A2 activity of endonexin.
Fauvel J; Salles JP; Roques V; Chap H; Rochat H; Douste-Blazy L
FEBS Lett; 1987 May; 216(1):45-50. PubMed ID: 2953628
[TBL] [Abstract][Full Text] [Related]
15. Effect of selective chemical modification and CNBr-cleavage at methionine20 in catalytic activity and substrate binding properties of porcine pancreatic phospholipase A2.
van der Wiele FC; Dekker N; Van Scharrenburg GJ; Hartskeerl RA; Meijer H; De Haas GH; Van Deenen LL; Slotboom AJ
Biochimie; 1988 Sep; 70(9):1215-22. PubMed ID: 3147714
[TBL] [Abstract][Full Text] [Related]
16. Independent folding and ligand specificity of the C2 calcium-dependent lipid binding domain of cytosolic phospholipase A2.
Nalefski EA; McDonagh T; Somers W; Seehra J; Falke JJ; Clark JD
J Biol Chem; 1998 Jan; 273(3):1365-72. PubMed ID: 9430670
[TBL] [Abstract][Full Text] [Related]
17. Sedimentation equilibrium analysis of five lipocortin-related phospholipase A2 inhibitors from human placenta. Evidence against a mechanistically relevant association between enzyme and inhibitor.
Ahn NG; Teller DC; Bienkowski MJ; McMullen BA; Lipkin EW; de Haën C
J Biol Chem; 1988 Dec; 263(35):18657-63. PubMed ID: 2974032
[TBL] [Abstract][Full Text] [Related]
18. Enhanced interfacial catalysis and hydrolytic specificity of phospholipase A2 toward peroxidized phosphatidylcholine vesicles.
Salgo MG; Corongiu FP; Sevanian A
Arch Biochem Biophys; 1993 Jul; 304(1):123-32. PubMed ID: 8323278
[TBL] [Abstract][Full Text] [Related]
19. Binding of quinacrine to acidic phospholipids and pancreatic phospholipase A2. Effects on the catalytic activity of the enzyme.
Mustonen P; Lehtonen JY; Kinnunen PK
Biochemistry; 1998 Sep; 37(35):12051-7. PubMed ID: 9724516
[TBL] [Abstract][Full Text] [Related]
20. Calcium-dependent and -independent interfacial binding and catalysis of cytosolic group IV phospholipase A2.
Hixon MS; Ball A; Gelb MH
Biochemistry; 1998 Jun; 37(23):8516-26. PubMed ID: 9622504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
